"Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial." by Ferguson Jj

Selected Works of Steven Borzak, MD, FACC

Article

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

JAMA (2004)

Ferguson Jj
Califf Rm
Antman Em
Cohen M
Grines Cl
Goodman S
Kereiakes Dj
Langer A
Mahaffey Kw
Nessel Cc
Armstrong Pw
Avezum A
Aylward P
Becker Rc
Biasucci L
Borzak S
Col J
Frey Mj
Fry E
Gulba Dc
Guneri S
Gurfinkel E
Harrington R
Hochman Js
Kleiman Ns, DeBakey Heart & Vascular Center
Leon Mb
Lopez-Sendon Jl
Pepine Cj
Ruzyllo W
Steinhubl
Teirstein Ps
Toro-Figueroa L
White H
Synergy Trial Investigators

Link

Disciplines

Publication Date

July 7, 2004

DOI

10.1001/JAMA.292.1.45

Citation Information

Ferguson Jj, Califf Rm, Antman Em, Cohen M, et al.. "Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial." JAMA Vol. 292 Iss. 1 (2004) p. 45 - 54
Available at: http://works.bepress.com/steven-borzak/53/